![Michel Elhorry](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenance du réseau au premier degré de Michel Elhorry
Entité | Type d'entité | Industrie | |
---|---|---|---|
IRDI Capital Investissement SAS
![]() IRDI Capital Investissement SAS Investment ManagersFinance IRDI Capital Investissement SAS(IRDI Capital) is an independent French regional venture capital/private equity firm which was established in 1981 by Alain Savary. The firm is headquartered in Toulouse.
6
| Private Company | Investment Managers | 6 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Michel Elhorry via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
IXO Private Equity SAS
![]() IXO Private Equity SAS Investment ManagersFinance IXO Private Equity SAS (IXO-PE) is an independent France-based regional private equity firm which was founded in 2002. Headquartered in Toulouse with an office in Bordeaux, the firm was previously known as ICSO Gestion. Their culture emphasizes regional development and local employment creation. The firm manages FCPR limited partnership venture capital funds for institutions and FIP regional development funds for individual investors. IXO-PE's institutional clients include local collectivities, insurance companies and international corporations as well as regional, national and European banks. | Investment Managers | Private Equity Analyst Private Equity Investor Private Equity Analyst Private Equity Analyst Private Equity Investor | |
ACCÈS INDUSTRIE | Finance/Rental/Leasing | Director/Board Member | |
IXALTIS SAS
![]() IXALTIS SAS Pharmaceuticals: MajorHealth Technology IXALTIS SAS develops therapeutics to treat genitourinary tract disorders with unsatisfied medical need. The company was founded by Christian Chavy, Philippe Lluel, Roberto Gradnik, Stefano Palea, Pascal Rischmann, and Xavier Gamé in 2012 and is headquartered in Archamps, France. | Pharmaceuticals: Major | Director/Board Member | |
Antabio SAS
![]() Antabio SAS Pharmaceuticals: MajorHealth Technology Antabio SAS operates as a biopharmaceutical company which develops drugs for the treatment and prevention of antibiotic-resistant bacterial infections. The firm focuses bacterial disease research, drug design, antibiotic combination testing, and in vitro technology development operations. The company was founded by Marc Lemonnier and Aymeric Dugray on October 15, 2009 and is headquartered in Labege, France. | Pharmaceuticals: Major | Director/Board Member |
Statistiques
Internationale
France | 6 |
Sectorielle
Finance | 4 |
Health Technology | 3 |
Opérationnelle
Private Equity Analyst | 7 |
Private Equity Investor | 7 |
Director/Board Member | 3 |
Relations les plus connectées
- Bourse
- Insiders
- Michel Elhorry
- Connexions Sociétés